Pittenger & Anderson Inc’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-150
Closed -$3.53K 481
2023
Q1
$3.53K Hold
150
﹤0.01% 400
2022
Q4
$4.19K Hold
150
﹤0.01% 388
2022
Q3
$4K Hold
150
﹤0.01% 392
2022
Q2
$5K Hold
150
﹤0.01% 376
2022
Q1
$5K Sell
150
-40
-21% -$1.37K ﹤0.01% 384
2021
Q4
$6K Buy
190
+32
+20% +$1.04K ﹤0.01% 384
2021
Q3
$5K Sell
158
-50
-24% -$1.6K ﹤0.01% 395
2021
Q2
$6K Buy
+208
New +$6.85K ﹤0.01% 350

Other funds holding OGN

Pittenger & Anderson Inc's OGN Position: Q2 2023 in Review

Pittenger & Anderson Inc sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 150 shares — an estimated $3.53K sold.

Pittenger & Anderson Inc first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $6K in Q4 2021. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Pittenger & Anderson Inc reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • Pittenger & Anderson Inc sold 150 Organon & Co shares in Q2 2023, an estimated $3.53K.
  • Pittenger & Anderson Inc first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
  • Pittenger & Anderson Inc's Organon & Co position peaked at $6K in Q4 2021.
  • 726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Pittenger & Anderson Inc's 13F filing for Q2 2023, filed 9 Aug 2023.